FDA Approves J&J's Icotyde for Plaque Psoriasis
The US FDA has approved Johnson & Johnson's Icotyde for plaque psoriasis, adding a new systemic option for dermatologists in a crowded therapeutic market.
Topic
Icotyde
Topic
Icotyde
FDA Approves Icotyde for Moderate-to-Severe Plaque Psoriasis
The FDA has approved Icotyde for moderate-to-severe plaque psoriasis in adults and adolescents, expanding systemic options for de…